JP2022543598A5 - - Google Patents

Info

Publication number
JP2022543598A5
JP2022543598A5 JP2022506697A JP2022506697A JP2022543598A5 JP 2022543598 A5 JP2022543598 A5 JP 2022543598A5 JP 2022506697 A JP2022506697 A JP 2022506697A JP 2022506697 A JP2022506697 A JP 2022506697A JP 2022543598 A5 JP2022543598 A5 JP 2022543598A5
Authority
JP
Japan
Prior art keywords
pain
nle
tic
seq
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022506697A
Other languages
English (en)
Japanese (ja)
Other versions
JP7651553B2 (ja
JP2022543598A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/044045 external-priority patent/WO2021021915A1/en
Publication of JP2022543598A publication Critical patent/JP2022543598A/ja
Publication of JP2022543598A5 publication Critical patent/JP2022543598A5/ja
Application granted granted Critical
Publication of JP7651553B2 publication Critical patent/JP7651553B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022506697A 2019-08-01 2020-07-29 ケメリン類似体を含む組成物とその使用方法 Active JP7651553B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962881725P 2019-08-01 2019-08-01
US62/881,725 2019-08-01
PCT/US2020/044045 WO2021021915A1 (en) 2019-08-01 2020-07-29 Compositions comprising chemerin analogs and methods of use

Publications (3)

Publication Number Publication Date
JP2022543598A JP2022543598A (ja) 2022-10-13
JP2022543598A5 true JP2022543598A5 (enExample) 2023-08-07
JP7651553B2 JP7651553B2 (ja) 2025-03-26

Family

ID=72087242

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022506697A Active JP7651553B2 (ja) 2019-08-01 2020-07-29 ケメリン類似体を含む組成物とその使用方法

Country Status (6)

Country Link
US (1) US12559523B2 (enExample)
EP (2) EP4007635B1 (enExample)
JP (1) JP7651553B2 (enExample)
AU (1) AU2020321898B2 (enExample)
CA (1) CA3149397A1 (enExample)
WO (1) WO2021021915A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023220676A2 (en) * 2022-05-12 2023-11-16 Okyo Pharma Limited Formulation for treating dry eye disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7419658B2 (en) * 2001-07-09 2008-09-02 Euroscreen S.A. Isolated ligand of ChemerinR
US20090053831A1 (en) * 2007-05-01 2009-02-26 Cell Signaling Technology, Inc. Tyrosine phosphorylation sites
JP2010229093A (ja) * 2009-03-27 2010-10-14 Banyu Pharmaceut Co Ltd 新規ＣｈｅｍｅｒｉｎＲアゴニスト
US20170039314A1 (en) * 2010-03-23 2017-02-09 Iogenetics, Llc Bioinformatic processes for determination of peptide binding
WO2013117581A1 (en) 2012-02-10 2013-08-15 Charite - Universitätsmedizin Berlin Metabolically stable variants of chemerin 9
WO2014168721A2 (en) * 2013-04-12 2014-10-16 Tufts Medical Center Methods and systems for designing and/or characterizing soluble lipidated ligand agents
ES2805037T3 (es) * 2016-01-22 2021-02-10 Tufts Medical Ct Inc Compuestos y métodos para tratar la inflamación
CN109134610B (zh) 2017-06-27 2022-07-08 尚华医药科技(江西)有限公司 一种肽类化合物、其应用及含其的组合物

Similar Documents

Publication Publication Date Title
JP2023002662A5 (enExample)
AU2018357775B2 (en) New combination of active agents for the treatment of progressive fibrosing interstitial lung diseases (PF-ILD)
JP6837486B2 (ja) 加齢に関連する認知障害及び神経炎症を予防及び／又は治療する方法
JP2015526458A5 (enExample)
JP2024075655A5 (ja) 鏡像異性体的に純粋なブプロピオンの医薬の製造における使用
EA201270144A1 (ru) Комбинированная терапия при лечении диабета
JP2018507243A5 (enExample)
ES2704229T3 (es) Agonistas selectivos del receptor AT2 para su uso en el tratamiento de la caquexia
JP2009544585A5 (enExample)
JP2023500032A5 (enExample)
IL265761B2 (en) Oral terlipressin compositions for use in treatment of ascites
JP2023537921A5 (enExample)
JP2022533968A5 (enExample)
EP4520394A3 (en) New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases
JP2022523530A5 (enExample)
CN107137417B (zh) 一种用于治疗恶病质的药物组合物及其应用
JP2023531930A5 (enExample)
WO2009123206A1 (ja) 経口医薬組成物
JP2016505050A5 (enExample)
CN116115619B (zh) 利培酮在治疗器官纤维化中的应用
US10258632B2 (en) Method of prevention of neurological diseases
JP2019507786A5 (enExample)
US20210393549A1 (en) New use of R-enantiomer of adrenergic beta 2 receptor agonists for treatment of inflammatory bowel disease and its extra intestinal manifestations
US20210137905A1 (en) 1-piperidinepropionic acid for treating a fibrosing disease
CN114288289A (zh) 具有镇痛和/或止痒功能的药物组合物及其应用